Upbeat Vascepa Expectations Boost Amarin Stock

Options traders have been eyeing the $20 level, too

by Karee Venema

Published on Jul 2, 2019 at 9:37 AM

Amarin Corporation plc (NASDAQ:AMRN) stock is trading up 6.8% at $20.55 this morning, after the cardiovascular disease specialist said it expects 2019 revenue to arrive between $380 million and $420 million -- up from the previous $350 million estimate -- on improved expectations for Vascepa, with a Food and Drug Administration (FDA) expected to vote on possible expansion of the heart drug's label by the end of this quarter.

Today's upside puts AMRN shares above short-term congestion in the round $20 region. The drug stock has gained 47% year-to-date, with its recent chop higher supported by its 180-day moving average.

Options traders have been targeting the $20 level, too, with the July 20 call one of AMRN's most heavily populated strikes. Data points to a mix of buying and selling here, with those purchasing the calls betting on a breakout above $20, while those writing the calls expecting the level to serve as a near-term ceiling.

It's certainly a more attractive time to buy premium on short-term Amarin options, versus sell it. The stock's Schaeffer's Volatility Index (SVI) of 56% ranks in the bottom percentile of its annual range, meaning front-month contracts are pricing in unusually low volatility expectations at the moment.


a schaeffer's exclusive

PLAY TRENDS LIKE A PRO!

5 tips to leverage profits in this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Trend Minting Millionaires -- But Who Is Really Paying?
Porter Stansberry is making a concerning prediction.
Roller Coaster Week Defined by Trade Headlines, Jobs Report
The Dow made outsized moves in both directions this week
Needham is Buying Trade Desk Ahead of the 2020 Election
Trade Desk stock has more than doubled in 2019
The Trend Minting Millionaires -- But Who Is Really Paying?
Porter Stansberry is making a concerning prediction.